BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20683667)

  • 1. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
    Mevorach D
    Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against C1q in systemic lupus erythematosus are antigen-driven.
    Schaller M; Bigler C; Danner D; Ditzel HJ; Trendelenburg M
    J Immunol; 2009 Dec; 183(12):8225-31. PubMed ID: 20007586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement deficiencies and systemic lupus erythematosus.
    Truedsson L; Bengtsson AA; Sturfelt G
    Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of anti-C1q autoantibodies to lupus nephritis.
    Tsirogianni A; Pipi E; Soufleros K
    Ann N Y Acad Sci; 2009 Sep; 1173():243-51. PubMed ID: 19758158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins.
    Sjöwall C; Wetterö J
    Clin Chim Acta; 2007 Mar; 378(1-2):13-23. PubMed ID: 17239838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA.
    Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B
    J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis--a hypothesis.
    Flierman R; Daha MR
    Mol Immunol; 2007 Jan; 44(1-3):133-8. PubMed ID: 16870257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients.
    Tsacheva I; Radanova M; Todorova N; Argirova T; Kishore U
    Mol Immunol; 2007 Mar; 44(8):2147-51. PubMed ID: 17049989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.